Template:Diuretics: Difference between revisions
Content deleted Content added
No edit summary |
No edit summary |
||
| (20 intermediate revisions by 13 users not shown) | |||
| Line 1: | Line 1: | ||
{{Navbox |
{{Navbox |
||
| name = Diuretics |
| name = Diuretics |
||
| title = [[ |
| title = [[Diuretic]]s ([[ATC code C03|C03]]) |
||
| state = {{{state<includeonly>|autocollapse</includeonly>}}} |
| state = {{{state<includeonly>|autocollapse</includeonly>}}} |
||
| listclass = hlist |
| listclass = hlist |
||
| Line 15: | Line 15: | ||
| list2 = |
| list2 = |
||
* [[Furosemide]]<sup>#</sup> |
* [[Furosemide]]<sup>#</sup> |
||
* [[Azosemide]] |
|||
* [[Bumetanide]] |
* [[Bumetanide]] |
||
* [[Etacrynic acid]] |
* [[Etacrynic acid]] |
||
* [[ |
* [[Etozolin]] |
||
* [[Indacrinone]] |
|||
* [[Muzolimine]] |
* [[Muzolimine]] |
||
* [[Ozolinone]] |
|||
* [[Piretanide]] |
* [[Piretanide]] |
||
* [[Tienilic acid]] |
* [[Tienilic acid]]<sup>‡</sup> |
||
* [[Torasemide]] |
* [[Torasemide]] |
||
| group3 = [[Thiazide]]s ([[Sodium-chloride symporter|Na-Cl]] at [[Distal convoluted tubule|DCT]],<br />[[Diuretic#Calcium-sparing diuretics|Calcium-sparing]]) |
| group3 = [[Thiazide]]s ([[Sodium-chloride symporter|Na-Cl]] at [[Distal convoluted tubule|DCT]],<br />[[Diuretic#Calcium-sparing diuretics|Calcium-sparing]]) |
||
| list3 = |
| list3 = |
||
*[[Altizide]] |
* [[Altizide]] |
||
* [[Bendroflumethiazide]] |
* [[Bendroflumethiazide]] |
||
| ⚫ | |||
* [[Chlorothiazide]] |
* [[Chlorothiazide]] |
||
* [[Cyclopenthiazide]] |
* [[Cyclopenthiazide]] |
||
* [[Cyclothiazide]] |
* [[Cyclothiazide]] |
||
*[[ |
* [[Epitizide]] |
||
* [[Hydrochlorothiazide]] |
* [[Hydrochlorothiazide]] |
||
* [[Hydroflumethiazide]] |
* [[Hydroflumethiazide]] |
||
* [[Mebutizide]] |
* [[Mebutizide]] |
||
| Line 40: | Line 44: | ||
| group4 = [[Thiazide-like diuretic|Thiazide-like]]s (primarily [[Distal convoluted tubule|DCT]]) |
| group4 = [[Thiazide-like diuretic|Thiazide-like]]s (primarily [[Distal convoluted tubule|DCT]]) |
||
| list4 = |
| list4 = |
||
| ⚫ | |||
* [[Clopamide]] |
|||
* [[Chlortalidone]] |
* [[Chlortalidone]] |
||
| ⚫ | |||
* [[Clofenamide]] |
* [[Clofenamide]] |
||
* [[ |
* [[Clopamide]] |
||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
* [[Clorexolone]] |
* [[Clorexolone]] |
||
* [[Fenquizone]] |
* [[Fenquizone]] |
||
| ⚫ | |||
| ⚫ | |||
| ⚫ | |||
* [[Metolazone]] |
|||
| ⚫ | |||
* [[Xipamide]] |
|||
}} |
}} |
||
| Line 60: | Line 64: | ||
| list1 = |
| list1 = |
||
* [[Amiloride]]<sup>#</sup> |
* [[Amiloride]]<sup>#</sup> |
||
| ⚫ | |||
* [[Benzamil]] |
* [[Benzamil]] |
||
| ⚫ | |||
| group2 = [[Antimineralocorticoid|Aldosterone antagonist]]s |
| group2 = [[Antimineralocorticoid|Aldosterone antagonist]]s |
||
| list2 = |
| list2 = |
||
* ''[[Spirolactone]]s'' |
|||
* [[Spironolactone]]<sup>#</sup> |
** [[Spironolactone]]<sup>#</sup> |
||
* [[Eplerenone]] |
|||
* [[ |
** [[Canrenone]] |
||
* [[ |
** [[Eplerenone]] |
||
** [[Potassium canrenoate]] |
|||
* ''[[Nonsteroidal]]'' |
|||
** [[Finerenone]] |
|||
}} |
}} |
||
| Line 75: | Line 83: | ||
| list3 = |
| list3 = |
||
* [[Mannitol]]<sup>#</sup> |
* [[Mannitol]]<sup>#</sup> |
||
* [[Glycerol]] |
|||
* [[Urea]] |
* [[Urea]] |
||
| group4 = [[Vasopressin receptor antagonist]]s<br />([[Distal convoluted tubule|DCT]] and [[Collecting duct|CD]]) |
| group4 = [[Vasopressin receptor antagonist|Vasopressin receptor inhibitor]]s<br />([[Distal convoluted tubule|DCT]] and [[Collecting duct|CD]]) |
||
| list4 = |
| list4 = |
||
* ''[[Vasopressin receptor antagonist#Vaptans| |
* ''[[Vasopressin receptor antagonist#Vaptans|Vaptans]]'' |
||
** [[Conivaptan]] |
|||
* [[Mozavaptan]] |
** [[Mozavaptan]] |
||
* [[Satavaptan]] |
** [[Satavaptan]] |
||
* [[Tolvaptan]] |
** [[Tolvaptan]] |
||
* ''[[Vasopressin receptor antagonist# |
* ''[[Vasopressin receptor antagonist#Demeclocycline and lithium|Others]]'' |
||
** [[Demeclocycline]] |
|||
** [[Lithium carbonate]] |
|||
| group5 = Other |
| group5 = Other |
||
| list5 = |
| list5 = |
||
* [[ |
* [[Ethanol]], [[Isopropanol]], [[tert-Amyl alcohol|2M2B]] |
||
* ''[[mercurial diuretic]]'' ([[Mersalyl]], [[Meralluride]]) |
* ''[[mercurial diuretic]]s'' ([[Chlormerodrin]], [[Mersalyl]], [[Meralluride]]) |
||
* [[Theobromine]] |
* [[Theobromine]] |
||
* [[Cicletanine]] |
* [[Cicletanine]] |
||
| group6 = |
| group6 = Combination products |
||
| list6 = |
|||
* [[Hydrochlorothiazide/triamterene]] |
|||
| group7 = |
|||
| belowstyle = background: transparent; padding: 0px; |
| belowstyle = background: transparent; padding: 0px; |
||
| below = {{PharmNavFootnote |
| below = {{PharmNavFootnote}} |
||
}}<noinclude> |
}}<noinclude> |
||
Latest revision as of 08:31, 16 November 2023
This template's initial visibility currently defaults to autocollapse, meaning that if there is another collapsible item on the page (a navbox, sidebar, or table with the collapsible attribute), it is hidden apart from its title bar; if not, it is fully visible.
To change this template's initial visibility, the |state= parameter may be used:
{{Diuretics|state=collapsed}}will show the template collapsed, i.e. hidden apart from its title bar.{{Diuretics|state=expanded}}will show the template expanded, i.e. fully visible.